Glossary Term Name
This is a placeholder for glossary term definitions.

Digg This Add To Delicious Add To Facebook Print Page

research funding facts

Fact Sheets: Research Funding Facts

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.3 billion to diabetes research, including more than $156 million in FY2008. Of this total more than $88 million represented new scientific projects. More than 85 percent of JDRF's expenditures directly support research and research-related education. In FY2008, the Foundation funded more than 1,000 centers, grants, and fellowships in 22 countries, including nearly 40 human clinical trials.

Areas of Scientific Investigation

* Artificial Pancreas
* Beta Cell Development
* Beta Cell Function
* Beta Cell Regeneration
* Clinical Trials
* Environmental Triggers
* Gene Therapy
* Genetics
* Hypoglycemia
* Immunology
* Islet Transplantation
* Nephropathy
* Neuropathy
* Retinopathy
* Stem Cells
* Technological Interventions
* Tolerance
* Wound Healing

JDRF's Research Goals
JDRF has established a set of cure therapeutic goals to guide its research funding efforts.  These research goal areas hold the greatest potential to lead to breakthrough cures and treatments for type 1 diabetes and its complications:

  • Autoimmunity: Stopping or reversing the immune system response that causes diabetes -- the attack on insulin-secreting cells in the pancreas.
  • Complications: Understanding how diabetes causes complications, and developing drugs, treatments, and therapies to stop that process, or reverse the impact of the different types of individual complications.
  • Replacement: Replacing cells killed off by diabetes with functioning ones from a donor -- similar to a heart or kidney transplant -- including increasing the supply of cells that can be transplanted.
  • Regeneration: Regenerating insulin-producing cells in people who have diabetes (as opposed to transplanting cells from organ donors or other sources).
  • Metabolic Control: Demonstrating that advanced monitoring tools might significantly improve the health of people with diabetes, and developing technologies that link insulin pumps and continuous glucose monitors.

FY 2008 JDRF Research Funding
Autoimmunity:                       $48.5 million
Complications:                       $28.9 million
Metabolic Control:                  $15.2 million
Regeneration:                        $21 million
Replacement:                        $42.8 million

For more information, visit the JDRF Web site at http://www.jdrf.org/, or call 800-533-CURE.

NOVEMBER 2008